Literature DB >> 9121179

Masseter muscle rigidity and nondepolarizing neuromuscular blocking agents.

A Albrecht1, D J Wedel, G A Gronert.   

Abstract

Masseter muscle rigidity has been identified as a possible risk factor for malignant hyperthermia (MH) and is usually noted in children receiving intravenously administered succinylcholine chloride after mask induction with halothane. Nondepolarizing muscle relaxants are considered safe for persons susceptible to MH. In this article, we present a case of clinically recognized jaw rigidity in the absence of succinylcholine after administration of a non-depolarizing muscle relaxant that was reported to the Malignant Hyperthermia Association of the United States hot line. The patient had recurrent jaw rigidity during subsequent anesthesia when a different non-depolarizing muscle relaxant was given. The North American MH Registry was then reviewed for similar cases. Three cases of masseter muscle rigidity in the presence of nondepolarizing muscle relaxants were discovered. Two of the patients were not found to be susceptible to MH; however, the third patient had positive findings on muscle biopsy. These cases do not provide enough information to confirm the ability of nondepolarizing muscle relaxants to cause jaw rigidity in the absence of MH.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121179     DOI: 10.4065/72.4.329

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  'Jaws of steel' after rocuronium.

Authors:  Monish S Raut; Arun Maheshwari; Aman Jyoti; Sandeep Joshi
Journal:  Indian J Anaesth       Date:  2016-02

2.  Masseter spasm after muscle relaxant.

Authors:  Monish S Raut; Arun Maheshwari
Journal:  Indian J Crit Care Med       Date:  2015-10

3.  Early Recognition and Treatment of Malignant Hyperthermia in Pediatric Patient during Bronchoscopy.

Authors:  Warangkana Lapisatepun; Supawan Arkarattanakul
Journal:  Case Rep Anesthesiol       Date:  2020-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.